Go, no-go decision making for phase 3 clinical trials: ACT IV revisited - Authors' reply.

Published

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Weller, M; Butowski, N; Tran, DD; Recht, LD; Lim, M; Hirte, H; Ashby, L; Mechtler, L; Goldlust, SA; Iwamoto, F; Drappatz, J; O'Rourke, DM; Wong, M; Hamilton, MG; Finocchiaro, G; Perry, J; Wick, W; Green, J; He, Y; Turner, CD; Yellin, MJ; Keler, T; Davis, TA; Stupp, R; Sampson, JH

Published Date

  • December 2017

Published In

Volume / Issue

  • 18 / 12

Start / End Page

  • e709 - e710

PubMed ID

  • 29208433

Pubmed Central ID

  • 29208433

Electronic International Standard Serial Number (EISSN)

  • 1474-5488

Digital Object Identifier (DOI)

  • 10.1016/S1470-2045(17)30856-2

Language

  • eng

Conference Location

  • England